Bionoid Pharma Inc. Announces Completion of 2024 Financial Audit
-
England vow to keep 'fighting and scrapping' as Ashes slip away
-
'Never enough': Conway leans on McKenzie wisdom in epic 300 stand
-
Most Asian markets track Wall St lower as AI fears mount
-
Cambodia says Thailand bombs casino hub on border
-
Thai queen wins SEA Games gold in sailing
-
England Ashes dreams on life-support as Australia rip through batting
-
Masterful Conway, Latham in 323 opening stand as West Indies wilt
-
Danish 'ghetto' tenants hope for EU discrimination win
-
Cricket Australia boss slams technology as Snicko confusion continues
-
Conway and Latham's 323-run opening stand batters hapless West Indies
-
Alleged Bondi shooters holed up in hotel for most of Philippines visit
-
Japan govt sued over 'unconstitutional' climate inaction
-
US approves $11 billion in arms sales to Taiwan: Taipei
-
England battle to save Ashes as Australia rip through top-order
-
Guarded and formal: Pope Leo XIV sets different tone
-
What to know about the EU-Mercosur deal
-
Trump vows economic boom, blames Biden in address to nation
-
Conway 120 as New Zealand in command at 216-0 against West Indies
-
Taiwan eyes fresh diplomatic ties with Honduras
-
ECB set to hold rates but debate swirls over future
-
Asian markets track Wall St lower as AI fears mount
-
EU holds crunch summit on Russian asset plan for Ukraine
-
Australia PM vows to stamp out hatred as nation mourns youngest Bondi Beach victim
-
Australian PM vows hate speech crackdown after Bondi Beach attack
-
Turkmenistan's battle against desert sand
-
Ukraine's Zelensky in Poland for first meeting with nationalist president
-
England in disarray at 59-3 in crunch Test as Lyon, Cummins pounce
-
Japan faces lawsuit over 'unconstitutional' climate inaction
-
Migrants forced to leave Canada after policy change feel 'betrayed'
-
What's next for Venezuela under the US oil blockade?
-
Salvadorans freed with conditional sentence for Bukele protest
-
Brazil Congress passes bill to cut Bolsonaro prison term
-
Cricket Australia boss slams technology 'howler' in Ashes Test
-
New Zealand 83-0 at lunch on day one of third West Indies Test
-
Ecuadorean footballer Mario Pineida shot and killed
-
US government admits liability in deadly DC air collision
-
Hemogenyx Pharmaceuticals PLC - Issue of Equity
-
SolePursuit Capital Syndicate Establishes Strategic Coordination Office and Appoints Laurence Kingsley as Head
-
1933 Industries Announces Maturity of Unsecured Convertible Debentures and Encourages Conversion to Support Continued Growth
-
Ex-podcaster Dan Bongino stepping down as deputy FBI director
-
Real Madrid scrape past third-tier Talavera in Spanish Cup
-
Hunt for US college mass shooter drags into fifth day
-
Cherki inspires Man City, Newcastle strike late to reach League Cup semis
-
Barcelona, Lyon and Chelsea reach Women's Champions League quarters
-
Venezuela reacts defiantly to US oil blockade, claims exports unaffected
-
Nasdaq tumbles on renewed angst over AI building boom
-
S.Africa expels Kenyans working on US Afrikaner 'refugee' applications
-
US Congress ends Syria sanctions
-
Cherki inspires Man City cruise into League Cup semis
-
Billionaire Trump nominee confirmed to lead NASA amid Moon race
NYSE - LSE
| SCS | 0.12% | 16.14 | $ | |
| CMSC | -0.34% | 23.26 | $ | |
| RBGPF | -2.23% | 80.22 | $ | |
| RIO | 1.55% | 77.19 | $ | |
| GSK | -0.14% | 48.71 | $ | |
| AZN | -1.66% | 89.86 | $ | |
| BCE | -0.78% | 23.15 | $ | |
| RYCEF | 1.48% | 14.86 | $ | |
| NGG | 1.8% | 77.16 | $ | |
| VOD | 0.86% | 12.81 | $ | |
| CMSD | -0.43% | 23.28 | $ | |
| BTI | -0.21% | 57.17 | $ | |
| BCC | 0.59% | 76.29 | $ | |
| JRI | -0.6% | 13.43 | $ | |
| RELX | -0.64% | 40.56 | $ | |
| BP | 2.06% | 34.47 | $ |
Bionoid Pharma Inc. Announces Completion of 2024 Financial Audit
NEW YORK CITY, NEW YORK / ACCESS Newswire / April 11, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the successful completion of its audited financial statements for the fiscal year ended December 31, 2024. The audit was conducted by Aloba Awomolo & Partners LLP, Chartered Professional Accountants, who were engaged earlier this year as Bionoid's external auditor.
"This marks an important milestone for Bionoid," said Wayne Cockburn, CEO of Bionoid Pharma. "Completing our 2024 audit puts us in a strong position as we now shift our focus toward the next phase of our corporate growth strategy - including the work required to advance our application to uplist to a more senior stock exchange. We remain committed to transparency, strong governance, and delivering long-term value to our shareholders."
The audited financial statements will be filed on https://www.otcmarkets.com/.
About Bionoid Pharma Inc.
Bionoid Pharma Inc. is a forward-thinking company focused on leveraging artificial intelligence to unlock new commercial opportunities and improve digital engagement. With a strategic emphasis on growth through acquisitions, Bionoid's five-year roadmap includes acquiring revenue-generating businesses and integrating its proprietary AI Maverick technology to enhance operational efficiency and user experience.
AI Maverick is a versatile, AI-powered platform designed to support a wide range of applications, from intelligent customer interaction tools to dynamic communication and data-driven engagement systems. As Bionoid continues to evolve, the flexibility of the Maverick platform provides a foundation for innovation across multiple sectors. Through these initiatives, the company aims to build long-term value, attract strategic partners, and establish a strong position in the rapidly expanding AI ecosystem.
Stay Connected:
Website: | |
OTC Markets: | BINP |
X (formerly Twitter): | @BionoidPharminc |
For Investor and Media Inquiries:
Wayne Cockburn, CEO
(905) 505-0770
Email: [email protected]
SOURCE: Bionoid Pharma, Inc.
View the original press release on ACCESS Newswire
R.Chavez--AT
